Pharma Pulse 9/27/24: Attracting Top Talent to Mega Campuses, OpenAI to Become For-Profit & more

Attracting Top Talent to Mega Campuses

In this part of his Pharmaceutical Executive video interview,Jonathan Scheinberg, of the Northeast Science and Technology Center, talks about strategies companies can adopt to attract and retain top talent in these competitive mega campus locations.

Pfizer Withdraws Voxelotor From Approved Markets, Will Discontinue Trials

The discontinuation comes after a review of the medication by the European Medicines Agency which found that “the total number of deaths was higher than anticipated.”

OpenAI to Become For-Profit Company

Planned restructuring comes amid personnel upheaval including resignation of chief technology officer.

Barbara Corcoran Announces Collaboration with Otsuka and Lundbeck to Raise Awareness of Agitation in Alzheimer’s Dementia

Barbara Corcoran, renowned entrepreneur, author, investor and caregiving advocate, is collaborating with Otsuka America Pharmaceutical, Inc. (Otsuka) and Lundbeck LLC (Lundbeck) to introduce ‘I Wish I Knew,’ a national public education campaign.

IMPACT SUPPLY CHAIN PARTNERS on LinkedIn

It was great to see our colleague, Kaushik Datta providing insights on the incredibly important topic of the Pharma Industry's work to minimize environmental impact and achieve their sustainability goals.

#Sustainability
#ImpactSupplyChainPartners

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs